GB virus C particles inhibit T cell activation via envelope E2 protein-mediated inhibition of TCR signaling

Journal of Immunology

Volumn 190, Issue 12, 2013, Pages 6351-6359

  Bhattarai, Nirjal ^a,b   McLinden, James H ^a,b   Xiang, Jinhua ^a,b   Landay, Alan L ^c   Chivero, Ernest T ^a   Stapleton, Jack T ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; GLYCOPROTEIN E2; HISTIDINE; PROTEIN KINASE LCK; SYNTHETIC PEPTIDE; T LYMPHOCYTE RECEPTOR; TYROSINE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; BYSTANDER T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL TYPE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ENZYME STRUCTURE; ENZYME SUBSTRATE; HEPATITIS G; HEPATITIS G VIRUS; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; IN VITRO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN MOTIF; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VIRUS PARTICLE;

ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GB VIRUS C; HEPATITIS, VIRAL, HUMAN; HUMANS; IMMUNOBLOTTING; JURKAT CELLS; LYMPHOCYTE ACTIVATION; RECEPTORS, ANTIGEN, T-CELL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; VIRAL ENVELOPE PROTEINS;

EID: 84879089779     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300589     Document Type: Article

References (41)

1. Stapleton, J. T., S. Foung, A. S. Muerhoff, J. Bukh, and P. Simmonds. 2011. The GB viruses: a review and proposed classification of GBV-A, GBV-C (HGV), and GBV-D in genus Pegivirus within the family Flaviviridae. J. Gen. Virol. 92: 233-246.
2. Mohr, E. L., J. Xiang, J. H. McLinden, T. M. Kaufman, Q. Chang, D. C. Montefiori, D. Klinzman, and J. T. Stapleton. 2010. GB virus type C envelope protein E2 elicits antibodies that react with a cellular antigen on HIV-1 particles and neutralize diverse HIV-1 isolates. J. Immunol. 185: 4496-4505.
3. Rey, D., J. Vidinic-Moularde, P. Meyer, C. Schmitt, S. Fritsch, J. M. Lang, and F. Stoll-Keller. 2000. High prevalence of GB virus C/hepatitis G virus RNA and antibodies in patients infected with human immunodeficiency virus type 1. Eur. J. Clin. Microbiol. Infect. Dis. 19: 721-724.
4. George, S. L., D. Varmaz, and J. T. Stapleton. 2006. GB virus C replicates in primary T and B lymphocytes. J. Infect. Dis. 193: 451-454. (Pubitemid 43122346)
5. Rydze, R. T., N. Bhattarai, and J. T. Stapleton. 2012. GB virus C infection is associated with a reduced rate of reactivation of latent HIV and protection against activation-induced T-cell death. Antivir. Ther. (Lond.) 17: 1271-1279.
6. Nunnari, G., L. Nigro, F. Palermo, M. Attanasio, A. Berger, H. W. Doerr, R. J. Pomerantz, and B. Cacopardo. 2003. Slower progression of HIV-1 infection in persons with GB virus C co-infection correlates with an intact T-helper 1 cytokine profile. Ann. Intern. Med. 139: 26-30.
7. Tillmann, H. L., H. Heiken, A. Knapik-Botor, S. Heringlake, J. Ockenga, J. C. Wilber, B. Goergen, J. Detmer, M. McMorrow, M. Stoll, et al. 2001. Infection with GB virus C and reduced mortality among HIV-infected patients. N. Engl. J. Med. 345: 715-724.
8. Williams, C. F., D. Klinzman, T. E. Yamashita, J. Xiang, P. M. Polgreen, C. Rinaldo, C. Liu, J. Phair, J. B. Margolick, D. Zdunek, et al. 2004. Persistent GB virus C infection and survival in HIV-infected men. N. Engl. J. Med. 350: 981-990. (Pubitemid 38269275)
9. Xiang, J., S. Wünschmann, D. J. Diekema, D. Klinzman, K. D. Patrick, S. L. George, and J. T. Stapleton. 2001. Effect of coinfection with GB virus C on survival among patients with HIV infection. N. Engl. J. Med. 345: 707-714.
10. Zhang, W., K. Chaloner, H. L. Tillmann, C. F. Williams, and J. T. Stapleton. 2006. Effect of early and late GB virus C viraemia on survival of HIV-infected individuals: a meta-analysis. HIV Med. 7: 173-180. (Pubitemid 43337596)
11. Bhattarai, N., and J. T. Stapleton. 2012. GB virus C: the good boy virus? Trends Microbiol. 20: 124-130.
12. Bhattarai, N., J. H. McLinden, J. Xiang, T. M. Kaufman, and J. T. Stapleton. 2012. GB virus C envelope protein E2 inhibits TCR-induced IL-2 production and alters IL-2-signaling pathways. J. Immunol. 189: 2211-2216.
13. Bhattarai, N., R. T. Rydze, E. T. Chivero, and J. T. Stapleton. 2012b. GB virus C viremia is associated with higher levels of double-negative T cells and lower T-cell activation in HIV-infected individuals receiving antiretroviral therapy. J. Infect. Dis. 206: 1469-1472.
14. Maidana-Giret, M. T., T. M. Silva, M. M. Sauer, H. Tomiyama, J. E. Levi, K. C. Bassichetto, A. Nishiya, R. S. Diaz, E. C. Sabino, R. Palacios, and E. G. Kallas. 2009. GB virus type C infection modulates T-cell activation independently of HIV-1 viral load. AIDS 23: 2277-2287.
15. Schwarze-Zander, C., M. Neibecker, S. Othman, C. Tural, B. Clotet, J. T. Blackard, B. Kupfer, G. Luechters, R. T. Chung, J. K. Rockstroh, and U. Spengler. 2010. GB virus C coinfection in advanced HIV type-1 disease is associated with low CCR5 and CXCR4 surface expression on CD4(+) T-cells. Antivir. Ther. (Lond.) 15: 745-752.
16. Stapleton, J. T., K. Chaloner, J. A. Martenson, J. Zhang, D. Klinzman, J. Xiang, W. Sauter, S. N. Desai, and A. Landay. 2012. GB virus C infection is associated with altered lymphocyte subset distribution and reduced T cell activation and proliferation in HIV-infected individuals. PLoS ONE 7: e50563.
17. Stapleton, J. T., K. Chaloner, J. Zhang, D. Klinzman, I. E. Souza, J. Xiang, A. Landay, J. Fahey, R. Pollard, and R. Mitsuyasu. 2009. GBV-C viremia is associated with reduced CD4 expansion in HIV-infected people receiving HAART and interleukin-2 therapy. AIDS 23: 605-610.
18. Grossman, Z., M. Meier-Schellersheim, W. E. Paul, and L. J. Picker. 2006. Pathogenesis of HIV infection: what the virus spares is as important as what it destroys. Nat. Med. 12: 289-295. (Pubitemid 43355074)
19. Hazenberg, M. D., S. A. Otto, B. H. van Benthem, M. T. Roos, R. A. Coutinho, J. M. Lange, D. Hamann, M. Prins, and F. Miedema. 2003. Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS 17: 1881-1888. (Pubitemid 37070273)
20. Hunt, P. W., J. Brenchley, E. Sinclair, J. M. McCune, M. Roland, K. Page-Shafer, P. Hsue, B. Emu, M. Krone, H. Lampiris, et al. 2008. Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J. Infect. Dis. 197: 126-133. (Pubitemid 351263476)
21. Vinikoor, M. J., A. Cope, C. L. Gay, G. Ferrari, K. S. McGee, J. D. Kuruc, J. L. Lennox, D. M. Margolis, C. B. Hicks, and J. J. Eron. 2013. Antiretroviral therapy initiated during acute HIV infection fails to prevent persistent T cell activation. J. Acquir. Immune Defic. Syndr. 62: 505-508.
22. Deeks, S. G., C. M. Kitchen, L. Liu, H. Guo, R. Gascon, A. B. Narváez, P. Hunt, J. N. Martin, J. O. Kahn, J. Levy, et al. 2004. Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood 104: 942-947. (Pubitemid 39038012)
23. Hunt, P. W., J. N. Martin, E. Sinclair, B. Bredt, E. Hagos, H. Lampiris, and S. G. Deeks. 2003. T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. J. Infect. Dis. 187: 1534-1543. (Pubitemid 36578959)
24. Xiang, J., J. H. McLinden, Q. Chang, T. M. Kaufman, and J. T. Stapleton. 2006. An 85-aa segment of the GB virus type C NS5A phosphoprotein inhibits HIV-1 replication in CD4+ Jurkat T cells. Proc. Natl. Acad. Sci. USA 103: 15570- 15575.
25. Xiang, J., J. H. McLinden, T. M. Kaufman, E. L. Mohr, N. Bhattarai, Q. Chang, and J. T. Stapleton. 2012. Characterization of a peptide domain within the GB virus C envelope glycoprotein (E2) that inhibits HIV replication. Virology 430: 53-62.
26. Bala, S., J. Petrasek, S. Mundkur, D. Catalano, I. Levin, J. Ward, H. Alao, K. Kodys, and G. Szabo. 2012. Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases. Hepatology 56: 1946-1957.
27. Fabbri, M., A. Paone, F. Calore, R. Galli, E. Gaudio, R. Santhanam, F. Lovat, P. Fadda, C. Mao, G. J. Nuovo, et al. 2012. MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proc. Natl. Acad. Sci. USA 109: E2110-E2116.
28. Singh, P. P., V. L. Smith, P. C. Karakousis, and J. S. Schorey. 2012. Exosomes isolated from mycobacteria-infected mice or cultured macrophages can recruit and activate immune cells in vitro and in vivo. J. Immunol. 189: 777-785.
29. Zhuang, G., X. Wu, Z. Jiang, I. Kasman, J. Yao, Y. Guan, J. Oeh, Z. Modrusan, C. Bais, D. Sampath, and N. Ferrara. 2012. Tumour-secreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK-STAT pathway. EMBO J. 31: 3513-3523.
30. Xiang, J., D. Klinzman, J. McLinden, W. N. Schmidt, D. R. LaBrecque, R. Gish, and J. T. Stapleton. 1998. Characterization of hepatitis G virus (GB-C virus) particles: evidence for a nucleocapsid and expression of sequences upstream of the E1 protein. J. Virol. 72: 2738-2744. (Pubitemid 28175509)
31. Dreux, M., U. Garaigorta, B. Boyd, E. Décembre, J. Chung, C. Whitten-Bauer, S. Wieland, and F. V. Chisari. 2012. Short-range exosomal transfer of viral RNA from infected cells to plasmacytoid dendritic cells triggers innate immunity. Cell Host Microbe 12: 558-570.
32. Masciopinto, F., C. Giovani, S. Campagnoli, L. Galli-Stampino, P. Colombatto, M. Brunetto, T. S. Yen, M. Houghton, P. Pileri, and S. Abrignani. 2004. Association of hepatitis C virus envelope proteins with exosomes. Eur. J. Immunol. 34: 2834-2842. (Pubitemid 39430159)
33. Meckes, D. G., Jr., and N. Raab-Traub. 2011. Microvesicles and viral infection. J. Virol. 85: 12844-12854.
34. Davis, S. J., and P. A. van der Merwe. 2011. Lck and the nature of the T cell receptor trigger. Trends Immunol. 32: 1-5.
35. Obenauer, J. C., L. C. Cantley, and M. B. Yaffe. 2003. Scansite 2.0: Proteome-wide prediction of cell signaling interactions using short sequence motifs. Nucleic Acids Res. 31: 3635-3641. (Pubitemid 37442212)
36. Xue, Y., J. Ren, X. Gao, C. Jin, L. Wen, and X. Yao. 2008. GPS 2.0, a tool to predict kinase-specific phosphorylation sites in hierarchy. Mol. Cell. Proteomics 7: 1598-1608.
37. Alexandropoulos, K., G. Cheng, and D. Baltimore. 1995. Proline-rich sequences that bind to Src homology 3 domains with individual specificities. Proc. Natl. Acad. Sci. USA 92: 3110-3114.
38. Saksela, K., G. Cheng, and D. Baltimore. 1995. Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for down-regulation of CD4. EMBO J. 14: 484-491.
39. Krey, T., J. d'Alayer, C. M. Kikuti, A. Saulnier, L. Damier-Piolle, I. Petitpas, D. X. Johansson, R. G. Tawar, B. Baron, B. Robert, et al. 2010. The disulfide bonds in glycoprotein E2 of hepatitis C virus reveal the tertiary organization of the molecule. PLoS Pathog. 6: e1000762.
40. Soto, P. C., L. L. Stein, N. Hurtado-Ziola, S. M. Hedrick, and A. Varki. 2010. Relative over-reactivity of human versus chimpanzee lymphocytes: implications for the human diseases associated with immune activation. J. Immunol. 184: 4185-4195.
41. Pichlmair, A., K. Kandasamy, G. Alvisi, O. Mulhern, R. Sacco, M. Habjan, M. Binder, A. Stefanovic, C. A. Eberle, A. Goncalves, et al. 2012. Viral immune modulators perturb the human molecular network by common and unique strategies. Nature 487: 486-490. of Research and Development